Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 11550286)

1.

Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas.

Guo M, Jia Y, Yu Z, House MG, Esteller M, Brock MV, Herman JG.

Discov Med. 2014 Feb;17(92):67-73.

2.

Inherited pancreatic cancer syndromes.

Solomon S, Das S, Brand R, Whitcomb DC.

Cancer J. 2012 Nov-Dec;18(6):485-91. doi: 10.1097/PPO.0b013e318278c4a6. Review.

3.

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.

de Wilde RF, Heaphy CM, Maitra A, Meeker AK, Edil BH, Wolfgang CL, Ellison TA, Schulick RD, Molenaar IQ, Valk GD, Vriens MR, Borel Rinkes IH, Offerhaus GJ, Hruban RH, Matsukuma KE.

Mod Pathol. 2012 Jul;25(7):1033-9. doi: 10.1038/modpathol.2012.53. Epub 2012 May 11.

4.

Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.

de Wilde RF, Edil BH, Hruban RH, Maitra A.

Nat Rev Gastroenterol Hepatol. 2012 Feb 7;9(4):199-208. doi: 10.1038/nrgastro.2012.9. Review.

5.

Pancreatic endocrine neoplasms: a current update on genetics and imaging.

Philips S, Shah SN, Vikram R, Verma S, Shanbhogue AK, Prasad SR.

Br J Radiol. 2012 Jun;85(1014):682-96. doi: 10.1259/bjr/85014761. Epub 2012 Jan 17. Review.

6.

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries.

Corbo V, Beghelli S, Bersani S, Antonello D, Talamini G, Brunelli M, Capelli P, Falconi M, Scarpa A.

Ann Oncol. 2012 Jan;23(1):127-34. doi: 10.1093/annonc/mdr048. Epub 2011 Mar 29.

7.

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.

Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A, delle Fave G, Pederzoli P, Croce CM, Scarpa A.

J Clin Oncol. 2010 Jan 10;28(2):245-55. doi: 10.1200/JCO.2008.21.5988. Epub 2009 Nov 16.

8.

II. The Endocrine and Pancreatic Unit at the University of Verona, Italy.

Gumbs AA.

HPB (Oxford). 2002;4(4):171-3. doi: 10.1080/13651820260503828. No abstract available.

9.

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.

Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F.

Br J Cancer. 2005 Jan 17;92(1):94-101.

10.

Genetic abnormalities in pancreatic cancer.

Moore PS, Beghelli S, Zamboni G, Scarpa A.

Mol Cancer. 2003 Jan 7;2:7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk